KLF4 and intestinal neoplasm: Interestingly, KLF4 promoter activity is inhibited by Notch, which controls goblet cell differentiation in mouse GI tract [16], when Notch signaling suppresses KLF4 expression to support intestinal tumors and CRC progression [17].